Chemistry of Materials,
Journal Year:
2024,
Volume and Issue:
36(3), P. 1088 - 1112
Published: Jan. 29, 2024
Cancer
immunotherapy,
aimed
at
reinvigorating
the
immune
system
to
induce
a
lasting
anticancer
response,
has
emerged
as
promising
approach
for
counteracting
evasive
tactics
of
cancer
cells.
This
study
delves
into
innovative
realm
stimuli-responsive
polymeric
nanomedicines
in
context
immunotherapy.
By
capitalizing
on
intricate
landscape
tumor
microenvironment
(TME),
which
orchestrates
suppression
and
progression,
offer
tailored
strategy
enhance
therapeutic
interventions.
The
aberrant
features
TME,
include
factors
such
low
pH,
inflammation,
oxidative
stress,
enzyme
overexpression,
serve
triggers
intelligent
delivery
systems
facilitated
by
functional
polymers.
dynamic
potential
overcome
challenges
faced
traditional
nanoparticle-based
immunotherapy
techniques,
presenting
platform
precisely
optimize
drug
within
locale.
As
synergistic
interaction
between
TME
unfolds,
novel
horizon
emerges
advance
efficacy
while
mitigating
its
associated
limitations.
Advanced Science,
Journal Year:
2021,
Volume and Issue:
9(1)
Published: Nov. 19, 2021
Abstract
The
past
decades
have
witnessed
great
progress
in
cancer
immunotherapy,
which
has
profoundly
revolutionized
oncology,
whereas
low
patient
response
rates
and
potential
immune‐related
adverse
events
remain
major
clinical
challenges.
With
the
advantages
of
controlled
delivery
modular
flexibility,
nanomedicine
offered
opportunities
to
strengthen
antitumor
immune
responses
sensitize
tumor
immunotherapy.
Furthermore,
tumor‐microenvironment
(TME)‐responsive
been
demonstrated
achieve
specific
localized
amplification
tissue
a
safe
effective
manner,
increasing
immunotherapy
reducing
side
effects
simultaneously.
Here,
recent
TME‐responsive
for
is
summarized,
responds
signals
TME,
such
as
weak
acidity,
reductive
environment,
high‐level
reactive
oxygen
species,
hypoxia,
overexpressed
enzymes,
adenosine
triphosphate.
Moreover,
combine
nanomedicine‐based
therapy
immunotherapeutic
strategies
overcome
each
step
cancer‐immunity
cycle
enhance
discussed.
Finally,
existing
challenges
further
perspectives
this
rising
field
with
hope
improved
development
applications
are
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(15), P. 5386 - 5417
Published: Jan. 1, 2023
Stimuli-activatable
strategies
prevail
in
the
design
of
nanomedicine
for
cancer
theranostics.Upon
exposure
to
endogenous/exogenous
stimuli,
stimuli-activatable
could
be
self-assembled,
disassembled,
or
functionally
activated
improve
its
biosafety
and
diagnostic/therapeutic
potency.A
myriad
tumor-specific
features,
including
a
low
pH,
high
redox
level,
overexpressed
enzymes,
along
with
exogenous
physical
stimulation
sources
(light,
ultrasound,
magnet,
radiation)
have
been
considered
nano-medicinal
products.Recently,
novel
stimuli
explored
elegant
designs
emerged
nanomedicine.In
addition,
multi-functional
theranostic
has
employed
imaging-guided
image-assisted
antitumor
therapy.In
this
review,
we
rationalize
development
clinical
pressing
needs.Stimuli-activatable
self-assembly,
disassembly
functional
activation
approaches
developing
realize
better
efficacy
are
elaborated
state-of-the-art
advances
their
structural
detailed.A
reflection,
status,
future
perspectives
provided.
Theranostics,
Journal Year:
2022,
Volume and Issue:
13(1), P. 295 - 323
Published: Dec. 19, 2022
Cancer
remains
a
severe
threat
to
human
health.
To
date,
although
various
therapeutic
methods,
including
radiotherapy
(RT),
chemotherapy,
chemodynamic
therapy
(CDT),
phototherapy,
starvation
therapy,
and
immunotherapy,
have
entered
new
stage
of
rapid
progress
in
cancer
theranostics,
their
limited
effect
significant
side
effects
need
be
considered
carefully.
With
the
development
nanotechnology,
marriage
nanomaterials
methods
provides
practical
possibility
improve
deficiencies
therapy.
Notably,
metal-organic
frameworks
(MOFs)
composed
ions/clusters
bridging
ligands
through
coordination
bonds
been
widely
applied
deal
with
drawbacks
different
such
as
effects,
low
stability,
poor
efficacy,
owing
controllable
morphologies,
tailorable
diameters,
diverse
compositions,
tunable
porosities,
high
specific
surface
areas,
facile
functionalization,
good
biocompatibility.
This
review
summarizes
recent
advanced
developments
achievements
multifunctional
MOF-based
nanoplatforms
for
single
RT,
CDT,
phototherapy
(photodynamic
photothermal
therapy),
combination
methods.
Moreover,
prospects
challenges
used
tumor
are
also
discussed.
ACS Applied Materials & Interfaces,
Journal Year:
2022,
Volume and Issue:
14(16), P. 18194 - 18208
Published: April 12, 2022
Bacterial
infection
has
been
a
considerable
obstacle
for
diabetic
wound
healing.
A
multifunctional
nanoplatform
used
as
nanozyme
bacterial
infected
is
extremely
attractive.
Therefore,
gold
nanoclusters
modified
zirconium-based
porphyrin
metal-organic
frameworks
(Au
NCs@PCN)
were
constructed
by
an
in
situ
growth
method.
Through
SEM,
TEM,
and
EDS
mapping,
the
surface
of
ellipsoid-shaped
particles
around
190
nm
was
observed
to
be
evenly
interspersed
with
5-8
nanoclusters.
Notably,
Au
NCs@PCN
exhibits
excellent
performance
exciting
ROS
generation
photothermal
effects.
Under
near-infrared
(NIR)
laser
irradiation,
can
heated
56.2
°C
produce
ROS,
showing
effective
killing
effect
on
bacteria.
Antibacterial
studies
showed
that
inhibited
MRSA
AmprE.
coli
destroying
membrane
structure
inducing
protein
leakage
up
95.3%
90.6%,
respectively.
Animal
experiments
treated
rats
had
reduced
coverage
2.7%
within
21
days.
The
immunoblot
analysis
proangiogenic
proepithelial
cell
proliferation
factors
expressed
significantly
up-regulated.
These
results
prove
photocatalytic
activity
broad
application
prospect
promoting
Advanced Science,
Journal Year:
2022,
Volume and Issue:
10(6)
Published: Dec. 25, 2022
Abstract
Nano‐immunotherapy
has
been
recognized
as
a
highly
promising
strategy
for
cancer
treatment
in
recent
decades,
which
combines
nanotechnology
and
immunotherapy
to
combat
against
tumors.
Hybrid
nanomaterials
consisting
of
at
least
two
constituents
with
distinct
compositions
properties,
usually
organic
inorganic,
have
engineered
integrated
functions
enormous
potential
boosting
immunotherapy.
This
review
provides
summary
hybrid
reported
immunotherapy,
including
nanoscale
metal–organic
frameworks,
metal–phenolic
networks,
mesoporous
organosilica
nanoparticles,
metallofullerene
nanomaterials,
polymer–lipid,
biomacromolecule‐based
nanomaterials.
The
combination
chemotherapy,
chemodynamic
therapy,
radiotherapy,
radiodynamic
photothermal
photodynamic
sonodynamic
therapy
based
on
is
also
discussed.
Finally,
the
current
challenges
prospects
designing
their
application
are
outlined.
Small Methods,
Journal Year:
2023,
Volume and Issue:
7(5)
Published: Jan. 5, 2023
Immunogenic
cell
death
(ICD,
also
known
as
immunogenic
apoptosis)
of
malignant
cells
is
confirmed
to
activate
the
host
immune
system
prevent,
control,
and
eliminate
tumors.
Recently,
a
range
chemotherapeutic
drugs
have
been
repurposed
ICD
inducers
applied
for
tumor
immunotherapy.
However,
several
hurdles
widespread
application
remain,
namely
poor
water
solubility,
short
blood
circulation,
non-specific
tissue
distribution,
severe
toxicity.
Recent
advances
in
nanotechnology
pharmaceutical
formulation
foster
development
nano
drug
delivery
systems
tackle
aforementioned
expedite
safe,
effective,
specific
delivery.
This
review
will
describe
barriers
chemical
highlight
recent
nanoformulations
these
Chemical Communications,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 23, 2024
This
review
explores
the
synthesis,
drug
loading,
and
surface
modifications
of
metal–organic
frameworks
(MOFs),
highlighting
their
role
in
improving
cancer
immunotherapy
paving
way
for
safer
more
effective
treatments.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(20)
Published: March 17, 2024
Abstract
Insufficient
tumor
immunogenicity
and
immune
escape
from
tumors
remain
common
problems
in
all
immunotherapies.
Recent
studies
have
shown
that
pyroptosis,
a
form
of
programmed
cell
death
is
accompanied
by
checkpoint
inhibitors,
can
induce
effective
immunogenic
long‐term
activation.
Therapeutic
strategies
to
jointly
pyroptosis
reverse
immunosuppressive
microenvironments
are
promising
for
cancer
immunotherapy.
In
this
regard,
dual‐responsive
supramolecular
polymeric
nanomedicine
(NCSNPs)
self‐cascade
amplify
the
benefits
immunotherapy
designed.
The
NCSNPs
formulated
β‐cyclodextrin
coupling
nitric
oxide
(NO)
donor,
activator,
NLG919,
an
indoleamine
2,3‐dioxygenase
(IDO)
inhibitor,
self‐assembled
through
host–guest
molecular
recognition
hydrophobic
interaction
obtain
nanoparticles.
possess
excellent
accumulation
bioavailability
attributed
ingenious
engineering.
study
not
only
confirms
occurrence
NO‐triggered
first
time
but
also
reverses
microenvironment
sites
via
IDO
inhibitor
enhancing
infiltration
cytotoxic
T
lymphocytes,
achieve
remarkable
inhibition
proliferation.
Thus,
provides
novel
strategy
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(26)
Published: July 22, 2022
Effective
pyroptosis
induction
is
a
promising
approach
to
potentiate
cancer
immunotherapy.
However,
the
actual
efficacy
of
present
inducers
can
be
weakened
by
successive
biological
barriers.
Here,
cascaded
pH-activated
supramolecular
nanoprodrug
(PDNP)
with
stepwise
size
shrinkage
property
developed
as
inducer
boost
antitumor
immune
response.
PDNPs
comprise
multiple
poly(ethylene
glycol)
(PEG)
and
doxorubicin
(DOX)
drug-polymer
hybrid
repeating
blocks
conjugated
ultra-pH-sensitive
benzoic
imine
(bzi)
hydrazone
(hyd)
bonds.
The
PEG
units
endow
its
"stealth"
ensure
sufficient
tumor
accumulation.
A
sharp
switch
in
particle
detachment
shielding
triggered
acidic
extracellular
pH
achieve
deep
intratumor
penetration.
Following
endocytosis,
second-stage
switching
initiated
more
endolysosomes,
disassociate
into
ultrasmall
cargo
accurate
intracellular
delivery.
activation
effectively
elicit
gasdermin
E
(GSDME)-mediated
enhance
immunological
In
combination
anti-PD-1
antibody,
amplify
suppression
extend
survival
mice,
which
suggests
powerful
adjuvant
pave
way
for
high-efficiency
checkpoint
blockade
therapy.
Bioactive Materials,
Journal Year:
2022,
Volume and Issue:
19, P. 38 - 49
Published: April 1, 2022
Ischemic
stroke
is
an
acute
and
serious
cerebral
vascular
disease,
which
greatly
affects
people's
health
brings
huge
economic
burden
to
society.
Microglia,
as
important
innate
immune
components
in
central
nervous
system
(CNS),
are
double-edged
swords
the
battle
of
nerve
injury,
considering
their
polarization
between
pro-inflammatory
M1
or
anti-inflammatory
M2
phenotypes.
High
mobility
group
box
1
(HMGB1)
one
potent
mediators
that
promotes
microglia.
18β-glycyrrhetinic
acid
(GA)
effective
intracellular
inhibitor
HMGB1,
but
poor
water
solubility
dose-dependent
toxicity.
To
overcome
shortcomings
GA
delivery
improve
efficacy
ischemia
therapy,
herein,
we
designed
reactive
oxygen
species
(ROS)
responsive
polymer-drug
conjugate
nanoparticles
(DGA)
manipulate
microglia
by
suppressing
translocation
nuclear
HMGB1.
DGA
presented
excellent
therapeutic
mice,
evidenced
reduction
infarct
volume,
recovery
motor
function,
suppressed
activation
enhanced
activation,
induction
neurogenesis.
Altogether,
our
work
demonstrates
a
close
association
HMGB1
polarization,
suggesting
potential
strategies
for
coping
with
inflammatory
microglia-related
diseases.